Singularity Fund

The Singular Fund focuses on public healthcare companies listed in mainland China. It not only follows the Activist Strategy, but also adjusts to the trading characteristics of A-shares.

Investment cases

Wondfo Biotech (300482.SZ): The leading POCT player in China

Kailaiying Biotech (002821.SZ): One of the top Chinese CDMO’s


©2018 DM Capital Ltd. All rights reserved